CU20200020A7 - Composición farmacéutica que comprende abx196 - Google Patents
Composición farmacéutica que comprende abx196Info
- Publication number
- CU20200020A7 CU20200020A7 CU2020000020A CU20200020A CU20200020A7 CU 20200020 A7 CU20200020 A7 CU 20200020A7 CU 2020000020 A CU2020000020 A CU 2020000020A CU 20200020 A CU20200020 A CU 20200020A CU 20200020 A7 CU20200020 A7 CU 20200020A7
- Authority
- CU
- Cuba
- Prior art keywords
- pharmaceutical composition
- abx196
- composition including
- formula
- bladder
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
<p>La presente invención se refiere a una composición farmacéutica que comprende el compuesto ABX 196 de la fórmula (I):</p> <p>ESPACIO PARA LA FÓRMULA</p> <p>útil en el tratamiento del cáncer de vejiga.</p>
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17306182 | 2017-09-13 | ||
| PCT/EP2018/074778 WO2019053142A1 (en) | 2017-09-13 | 2018-09-13 | ABX196 FOR USE IN THE TREATMENT OF BLADDER CANCER |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CU20200020A7 true CU20200020A7 (es) | 2020-11-30 |
Family
ID=60001797
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU2020000020A CU20200020A7 (es) | 2017-09-13 | 2018-09-13 | Composición farmacéutica que comprende abx196 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US11266667B2 (es) |
| EP (1) | EP3681512B1 (es) |
| JP (1) | JP7214718B2 (es) |
| KR (1) | KR20200102412A (es) |
| CN (1) | CN111182907B (es) |
| AU (1) | AU2018332046B2 (es) |
| BR (1) | BR112020004778A2 (es) |
| CA (1) | CA3075443A1 (es) |
| CU (1) | CU20200020A7 (es) |
| DK (1) | DK3681512T3 (es) |
| ES (1) | ES2893549T3 (es) |
| HR (1) | HRP20211351T1 (es) |
| IL (1) | IL273054B2 (es) |
| MX (1) | MX2020002812A (es) |
| PL (1) | PL3681512T3 (es) |
| PT (1) | PT3681512T (es) |
| WO (1) | WO2019053142A1 (es) |
| ZA (1) | ZA202001435B (es) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2231145B1 (en) * | 2007-12-05 | 2014-09-17 | Wittycell | Use of glycosylceramides for enhancing the immune response to antigens |
| CA2739765A1 (en) * | 2008-10-08 | 2010-04-15 | Vincent Serra | Vaccine composition for use against influenza |
| MX2019002947A (es) * | 2016-09-14 | 2019-07-22 | Abivax | Combinaciones que incluyen abx196 para el tratamiento de cancer. |
-
2018
- 2018-09-13 ES ES18765477T patent/ES2893549T3/es active Active
- 2018-09-13 MX MX2020002812A patent/MX2020002812A/es unknown
- 2018-09-13 EP EP18765477.7A patent/EP3681512B1/en active Active
- 2018-09-13 JP JP2020515026A patent/JP7214718B2/ja active Active
- 2018-09-13 AU AU2018332046A patent/AU2018332046B2/en active Active
- 2018-09-13 US US16/647,379 patent/US11266667B2/en active Active
- 2018-09-13 PT PT18765477T patent/PT3681512T/pt unknown
- 2018-09-13 DK DK18765477.7T patent/DK3681512T3/da active
- 2018-09-13 WO PCT/EP2018/074778 patent/WO2019053142A1/en unknown
- 2018-09-13 KR KR1020207007414A patent/KR20200102412A/ko not_active Application Discontinuation
- 2018-09-13 CA CA3075443A patent/CA3075443A1/en active Pending
- 2018-09-13 BR BR112020004778-3A patent/BR112020004778A2/pt unknown
- 2018-09-13 PL PL18765477T patent/PL3681512T3/pl unknown
- 2018-09-13 CU CU2020000020A patent/CU20200020A7/es unknown
- 2018-09-13 CN CN201880064390.5A patent/CN111182907B/zh active Active
-
2020
- 2020-03-04 IL IL273054A patent/IL273054B2/en unknown
- 2020-03-06 ZA ZA2020/01435A patent/ZA202001435B/en unknown
-
2021
- 2021-08-25 HR HRP20211351TT patent/HRP20211351T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3075443A1 (en) | 2019-03-21 |
| US11266667B2 (en) | 2022-03-08 |
| JP7214718B2 (ja) | 2023-01-30 |
| RU2020109889A3 (es) | 2022-01-28 |
| KR20200102412A (ko) | 2020-08-31 |
| HRP20211351T1 (hr) | 2021-11-26 |
| JP2020533368A (ja) | 2020-11-19 |
| ES2893549T3 (es) | 2022-02-09 |
| IL273054A (en) | 2020-04-30 |
| BR112020004778A2 (pt) | 2020-10-13 |
| CN111182907A (zh) | 2020-05-19 |
| CN111182907B (zh) | 2023-01-06 |
| ZA202001435B (en) | 2022-07-27 |
| IL273054B1 (en) | 2023-01-01 |
| PT3681512T (pt) | 2021-10-06 |
| AU2018332046B2 (en) | 2024-06-13 |
| PL3681512T3 (pl) | 2022-01-17 |
| US20200230163A1 (en) | 2020-07-23 |
| MX2020002812A (es) | 2020-07-21 |
| WO2019053142A1 (en) | 2019-03-21 |
| IL273054B2 (en) | 2023-05-01 |
| EP3681512A1 (en) | 2020-07-22 |
| EP3681512B1 (en) | 2021-08-04 |
| AU2018332046A1 (en) | 2020-03-19 |
| RU2020109889A (ru) | 2021-09-06 |
| DK3681512T3 (da) | 2021-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2019001714A1 (es) | Compuestos de amino-triazolopiridina y su uso en el tratamiento del cáncer. | |
| CL2018000318A1 (es) | Compuestos derivados de piridinona, inhibidores de bromodominio; composición farmacéutica que los comprende; y su uso en el tratamiento de enfermedades del cáncer. (solicitud divisional 201600925) | |
| CL2017002606A1 (es) | Inhibidor de bromodominio | |
| CL2019002304A1 (es) | Compuestos para el tratamiento del cáncer. | |
| CU24605B1 (es) | Pirimidin-2-il amino-1h-pirazoles útiles como inhibidores de lrrk2 | |
| SV2018005687A (es) | Derivados de dihidroimidazopirazinona usados en el tratamiento del cancer | |
| CR20180516A (es) | Compuestos de iprrolotriazina como inhibidores de tam | |
| CO2018000589A2 (es) | Oxiesteroles y composiciones farmacéuticas que los contienen | |
| CR20170116A (es) | Compuestos que inhiben la proteina mcl-1 | |
| DOP2016000085A (es) | Amino-heteroaril-benzamidas como inhibidores de cinasa | |
| GT201600123A (es) | Inhibidores de syk | |
| UY35353A (es) | Un inhibidor de mdm2 derivado de ácido benzoico para el tratamiento del cáncer | |
| CR20150078A (es) | Análogos de piridazina 1,4-disustituida y métodos para el tratamiento de condiciones relacionadas con la deficiencia de smn | |
| PE20151542A1 (es) | Compuestos de tetrahidropirrolotiazina | |
| PE20151654A1 (es) | Inhibidores de cdc7 | |
| CO2020007162A2 (es) | Derivado de oxi-fluoropiperidina como inhibidor de quinasa | |
| BR112020008664A8 (pt) | Composto macrocíclico que atua como inibidor de weel e aplicações do mesmo | |
| CO2019009423A2 (es) | Inhibidores de mnk sustituidos con piperidina y métodos relacionados con los mismos | |
| GT201500247A (es) | Imidazopiridazinas sustituidas | |
| NI201800071A (es) | Compuestos de isoindol | |
| UY36145A (es) | Compuestos de 1, 3, 4-tiadiazol y uso de los mismos para el tratamiento del cáncer | |
| AR095097A1 (es) | Compuestos de fenoxietoxi | |
| AR105821A1 (es) | COMPUESTOS ÚTILES PARA INHIBIR ROR-g-T | |
| MX2020004930A (es) | Compuestos de biarilo sustituido novedosos como inhibidores de indolamina 2,3-dioxigenasa (ido). | |
| CL2015002466A1 (es) | Formulaciones de compuestos orgánicos |